Myocardial Solutions’ software, MyoStrain, was featured in a new Vascular Health and Risk Management publication evaluating the use of cardiac imaging techniques in the diagnostic work-up for patients with suspected cardiac amyloidosis. Cardiac amyloidosis is a serious, progressive disease that....
Myocardial Solutions (“MSI”) announced the addition of three new board members: Bob Kay, Jeff Barber and Gary Brock. Jeff replaces Bill Burke as Chair of the Audit Committee. Bill was an outstanding Director but was forced to resign as a result of new time commitments after becoming Chairman...
Myocardial Solutions (“MSI”) announced the launch of their new dynamic website Monday to support the growing commercial and clinical initiatives to drive MyoStrain adoption. The newly updated website features an improved...
Myocardial Solutions’ software platform, MyoStrain, was featured in a new Journal of Cardiovascular Magnetic Resonance publication evaluating a multiparametric assessment of left ventricular hypertrophy (LVH). LVH, which can be a result of an array of diseases and conditions, makes determining the..
A recent study published in the Journal of Cardiovascular Magnetic Resonance featured Myocardial Solutions’ technology MyoStrain, where MyoStrain was used to examine myocardial tissue function in Wilson Disease (WD) patients. WD, a storage disease that results in...
